Skip to content
Disclosery

EXANE DERIVATIVES: KXI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on KXI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 611 KXI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 611 shares
    Change vs previous 13F -3,660 shares

    0.02% of the 13F portfolio, value $35,321.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4,271 shares
    Change vs previous 13F +640 shares

    0.07% of the 13F portfolio, value $265,255.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,631 shares
    Change vs previous 13F +361 shares

    0.06% of the 13F portfolio, value $235,028.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,270 shares
    Change vs previous 13F +2,976 shares

    0.05% of the 13F portfolio, value $196,095.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 294 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $18,013.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).